Pharmaceutical compositions and methods for insulin treatment

Details Pharmaceutical compositions and methods for insulin treatment Pharmaceutical compositions and methods for insulin treatment

2009-11-06

2011-10-25

Audet, Maury (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S001100, C514S006700, C514S006800, C514S006900, C424S001690

Reexamination Certificate

active

08044020

ABSTRACT:
Compositions and methods for treating a patient with insulin that combines insulin, a permeation enhancer, and a carrier that maintains an acidic pH, are disclosed.

REFERENCES:
patent: 5731303 (1998-03-01), Hsieh
patent: 5898028 (1999-04-01), Jensen et al.
patent: 2002/0123437 (2002-09-01), Conboy et al.
Pfister & Hseih “Permeation Enhancers Compatible With Transdermal Drug Delivery Systems Part II: System Design Considerations”, Medical Device Technology, pp. 54-60, Oct. 1990 (cited of record, not relied upon).
Pfister & Hseih Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations. Med Device Technol. Sep.-Oct. 1990;1(5):48-55) (cited of record, not relied upon).

Affiliated with

Also associated with

Rating

Pharmaceutical compositions and methods for insulin treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions and methods for insulin treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and methods for insulin treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4253817